Evidence map›Paper›PMID 30298965›Full record

ArticleNeurogastroenterology and motility2019

Brain corticotropin-releasing factor signaling: Involvement in acute stress-induced visceral analgesia in male rats.

Muriel Larauche, Nabila Moussaoui, Mandy Biraud, Won Ki Bae, Henri Duboc, Mulugeta Million, Yvette Taché

Open access · greenAbstract read
In one paragraph

Article in Neurogastroenterology and motility, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Oxytocin, Vasopressin and Stress: A Hormetic Perspective.Current issues in molecular biology · 2025
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Muriel LaraucheDepartment of Medicine, G Oppenheimer Center for Neurobiology of Stress and Resilience and CURE: Digestive Diseases Research Center, Vatche and Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine, UCLA, Los Angeles, California.ORCID 0000-0003-3320-3675
Nabila MoussaouiDepartment of Medicine, G Oppenheimer Center for Neurobiology of Stress and Resilience and CURE: Digestive Diseases Research Center, Vatche and Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine, UCLA, Los Angeles, California.
Mandy BiraudDepartment of Medicine, G Oppenheimer Center for Neurobiology of Stress and Resilience and CURE: Digestive Diseases Research Center, Vatche and Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine, UCLA, Los Angeles, California.
Won Ki BaeDepartment of Medicine, G Oppenheimer Center for Neurobiology of Stress and Resilience and CURE: Digestive Diseases Research Center, Vatche and Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine, UCLA, Los Angeles, California.
Henri DubocDepartment of Medicine, G Oppenheimer Center for Neurobiology of Stress and Resilience and CURE: Digestive Diseases Research Center, Vatche and Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine, UCLA, Los Angeles, California.
Mulugeta MillionDepartment of Medicine, G Oppenheimer Center for Neurobiology of Stress and Resilience and CURE: Digestive Diseases Research Center, Vatche and Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine, UCLA, Los Angeles, California.
Yvette TachéDepartment of Medicine, G Oppenheimer Center for Neurobiology of Stress and Resilience and CURE: Digestive Diseases Research Center, Vatche and Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine, UCLA, Los Angeles, California.
Center for Digestive and Liver Diseases · US

Funding

Pilot and Feasibility ProgramP30DK041301 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ROZENGURT, JUAN ENRIQUE · 1990 to 2019
$18.0M
Stress-Induced Activition of Colonic Motor FunctionR01DK057238 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI TACHE, YVETTE FRANCE · 2000 to 2015
$3.3M
Modulation of Colonic Response to Stress by Peripheral CRF2 ReceptorsR01DK078676 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MULUGETA, MILLION · 2008 to 2016
$2.2M
Modulation of Colonic Epithelial Permeability by Sex HormonesK01DK088937 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LARAUCHE, MURIEL · 2011 to 2015
$647k
Inje Research & Scholarship FoundationNational Institute of Diabetes and Digestive and Kidney Diseases K01 DK088937NIDDK NIH HHS K01 DK088937NIDDK NIH HHS P30 DK041301NIDDK NIH HHS P30 DK41301NIDDK NIH HHS R01 DK057238NIDDK NIH HHS R01 DK078676NIDDK NIH HHS R01 DK57238Société Nationale Francaise de Gastro-Entérologie (Bourse Robert Tournut)The Philippe Foundation
6 · The paper itself

Abstract

backgroundWater avoidance stress (WAS) induces a naloxone-independent visceral analgesia in male rats under non-invasive conditions of monitoring. The objective of the study was to examine the role of brain CRF signaling in acute stress-induced visceral analgesia (SIVA).

methodsAdult male Sprague-Dawley rats were chronically implanted with an intracerebroventricular (ICV) cannula. The visceromotor response (VMR) to graded phasic colorectal distension (CRD: 10, 20, 40, 60 mm Hg, 20 seconds, 4 minutes intervals) was monitored using manometry. The VMR to a first CRD (baseline) was recorded 5 minutes after an ICV saline injection, followed 1 hour later by ICV injection of either CRF (30, 100, or 300 ng and 1, 3, or 5 μg/rat) or saline and a second CRD, 5 minutes later. Receptor antagonists against CRF KEY

resultsICV CRF (100 and 300 ng) reduced the VMR to CRD at 60 mm Hg by -36.6% ± 6.8% and -48.7% ± 11.7%, respectively, vs baseline (P < 0.001), while other doses had no effect and IP CRF (10 µg/kg) induced visceral hyperalgesia. Astressin-B and tocinoic acid injected ICV induced hyperalgesia and prevented the analgesic effect of ICV CRF (300 ng/rat) and WAS, while astressin CONCLUSIONS & INFERENCES: These data support a role for brain CRF signaling via CRF

Indexed as

AnimalsBrainCorticotropin-Releasing HormoneHyperalgesiaMaleRatsRats, Sprague-DawleySignal TransductionStress, PsychologicalVisceral PainCorticotropin-Releasing Hormonecorticotropin-releasing factormanometryoxytocinstress-induced visceral analgesiawater avoidance stress

Identifiers

PMID30298965
PMCPMC6347489
OpenAlexW2896755224

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.